Understanding GWI: Integrative Modeling
Trial Summary
What is the purpose of this trial?
The investigator proposes to perform a Phase I study assessing safety, efficacy, and biomarker response to the therapeutic interventions of Etanercept followed by mifepristone for veterans with Gulf War Illness. The investigator will conduct and repeat the exercise challenge before treatment and on therapy to assess the impact of the interventions on homeostatic regulation and the dynamic model identified in prior studies.
Research Team
Nancy Klimas, MD
Principal Investigator
South Florida Veterans Affairs Foundation for Research and Education
Eligibility Criteria
Inclusion Criteria
Treatment Details
Interventions
- Etanercept (Monoclonal Antibodies)
- Mifepristone (Corticosteroid)
Etanercept is already approved in Canada for the following indications:
- Rheumatoid Arthritis
- Juvenile Idiopathic Arthritis
- Psoriatic Arthritis
- Ankylosing Spondylitis
- Plaque Psoriasis
Find a Clinic Near You
Who Is Running the Clinical Trial?
South Florida Veterans Affairs Foundation for Research and Education
Lead Sponsor
United States Department of Defense
Collaborator
Nova Southeastern University
Collaborator